Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONCY | BMY | AMGN | GILD | REGN |
| Company | Oncolytics Biotech Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0900 | 44.68 | 265.72 | 65.50 | 881.72 |
| High | 1.0994 | 45.13 | 271.68 | 66.35 | 887.48 |
| Low | 1.0600 | 44.34 | 265.72 | 64.63 | 875.23 |
| Last | 1.0800 | 45.12 | 269.91 | 65.28 | 884.43 |
| Change | -0.0100 | +0.42 | +0.53 | +0.01 | -6.25 |
| % Change | -0.93% | +0.94% | +0.20% | +0.02% | -0.70% |
| Volume | 69,199 | 3,454,467 | 231,003 | 3,098,114 | 97,030 |
| 20-Day Average Volume | 255,220 | 12,287,863 | 2,045,186 | 6,554,625 | 435,728 |
| Previous Close | 1.0800 | 44.70 | 269.38 | 65.27 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0925 | 49.48 | 270.03 | 68.28 | 918.60 |
| 20-Day Raw Stochastic | 21.43% | 6.67% | 43.56% | 5.36% | 9.53% |
| 20-Day Relative Strength | 48.85% | 29.97% | 46.35% | 27.89% | 33.35% |
| Weighted Alpha | -45.93 | -34.12 | +9.91 | -24.03 | +10.01 |
| Today's Opinion | 64% Sell | 88% Sell | 56% Sell | 100% Sell | 8% Sell |
| Previous Opinion | 64% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.94% since 04/19/24 | -8.03% since 04/19/24 | +0.70% since 04/19/24 | -2.50% since 04/19/24 | -1.40% since 04/19/24 |
| Low | 1.0294 on 04/24/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 1.1201 on 04/25/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | +5.94% since 03/26/24 | -14.37% since 03/26/24 | -3.89% since 03/26/24 | -10.11% since 03/26/24 | -8.23% since 03/26/24 |
| Low | 1.0000 on 03/27/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 1.2900 on 04/04/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -12.30% since 01/26/24 | -9.46% since 01/26/24 | -13.14% since 01/26/24 | -18.15% since 01/26/24 | -5.93% since 01/26/24 |
| Low | 0.8830 on 02/07/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 1.2900 on 04/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -31.41% since 10/26/23 | -15.05% since 10/26/23 | +0.40% since 10/26/23 | -17.08% since 10/26/23 | +11.65% since 10/26/23 |
| Low | 0.8830 on 02/07/24 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
| High | 1.8000 on 11/03/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 81,454 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
| Shares Outstanding, K | 75,420 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -20,560,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -2,870,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.93 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 03/07/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/03/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 24.12 |